MENU
+Compare
MAHLY
Stock ticker: OTC
AS OF
Jan 8 closing price
Price
$18.00
Change
+$0.60 (+3.45%)
Capitalization
3.7B

MAHLY stock forecast, quote, news & analysis

Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products... Show more

MAHLY
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for MAHLY with price predictions
Jan 14, 2026

MAHLY's RSI Indicator peaks and leaves overbought zone

The 10-day RSI Indicator for MAHLY moved out of overbought territory on December 30, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 instances where the indicator moved out of the overbought zone. In of the 20 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Moving Average Convergence Divergence Histogram (MACD) for MAHLY turned negative on January 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 14, 2026. You may want to consider a long position or call options on MAHLY as a result. In of 54 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 134 cases where MAHLY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MAHLY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.941) is normal, around the industry mean (9.492). P/E Ratio (14.616) is within average values for comparable stocks, (31.031). MAHLY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.599). Dividend Yield (0.024) settles around the average of (0.031) among similar stocks. P/S Ratio (0.159) is also within normal values, averaging (147.841).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MAHLY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.

A.I.Advisor
published Dividends

MAHLY paid dividends on June 18, 2024

Medipal Holdings Corp. MAHLY Stock Dividends
А dividend of $0.19 per share was paid with a record date of June 18, 2024, and an ex-dividend date of March 27, 2024. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are McKesson Corp (NYSE:MCK).

Industry description

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

Market Cap

The average market capitalization across the Medical Distributors Industry is 12.48B. The market cap for tickers in the group ranges from 557.05K to 102.96B. MCK holds the highest valuation in this group at 102.96B. The lowest valued company is CNBI at 557.05K.

High and low price notable news

The average weekly price growth across all stocks in the Medical Distributors Industry was 7%. For the same Industry, the average monthly price growth was 13%, and the average quarterly price growth was 29%. YI experienced the highest price growth at 99%, while COSM experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the Medical Distributors Industry was 35%. For the same stocks of the Industry, the average monthly volume growth was -63% and the average quarterly volume growth was 54%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 57
Price Growth Rating: 49
SMR Rating: 81
Profit Risk Rating: 79
Seasonality Score: 11 (-100 ... +100)
View a ticker or compare two or three
MAHLY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalDistributors

Profile
Fundamentals
Details
Industry
N/A
Address
2-7-15, Yaesu
Phone
+81 335175800
Employees
21731
Web
http://www.medipal.co.jp